# Meta Platforms timeline

entity: /record/meta.md  
id: ent_meta  

Meta Platforms' timeline holds 462 money & deals claims from 2009 to 2026. The latest took effect on October 29, 2026.

Kinds: People 18 (/timelines/meta.md?kind=people) · Money & deals 462 (/timelines/meta.md?kind=money) · Products 30 (/timelines/meta.md?kind=products) · Models 9 (/timelines/meta.md?kind=models) · Other 588 (/timelines/meta.md?kind=other) · every kind: /timelines/meta.md  
Format: date | kind | predicate | value | status | claim.

## 2009

- 2009-12-31 to 2010-12-31 | money | cash_and_equivalents | 633,000,000 United States dollar | superseded | [clm_A32A7C00F85F](/claim/clm_A32A7C00F85F.md)

## 2010

- 2010-12-31 to 2011-06-30 | money | cash_and_equivalents | 1,785,000,000 United States dollar | superseded | [clm_22E7D8F0B8B8](/claim/clm_22E7D8F0B8B8.md)
- 2010-12-31 to 2011-12-31 | money | net_income | 606,000,000 United States dollar | superseded | [clm_30F3EE61A8D2](/claim/clm_30F3EE61A8D2.md)
- 2010-12-31 to 2011-12-31 | money | operating_income | 1,032,000,000 United States dollar | superseded | [clm_A8B189C4536E](/claim/clm_A8B189C4536E.md)
- 2010-12-31 to 2011-12-31 | money | research_and_development | 144,000,000 United States dollar | superseded | [clm_1C1E77EFAF9F](/claim/clm_1C1E77EFAF9F.md)
- 2010-12-31 to 2011-12-31 | money | revenue | 1,974,000,000 United States dollar | superseded | [clm_4201BDA06D4D](/claim/clm_4201BDA06D4D.md)

## 2011

- 2011-03-31 to 2012-03-31 | money | employees | 2,431 | superseded | [clm_C0696347138C](/claim/clm_C0696347138C.md)
- 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 1,131,000,000 United States dollar | superseded | [clm_2CE3B3D1D038](/claim/clm_2CE3B3D1D038.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_net_income | 240,000,000 United States dollar | superseded | [clm_7EA798315617](/claim/clm_7EA798315617.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_operating_income | 407,000,000 United States dollar | superseded | [clm_2EFA9E5AF1E6](/claim/clm_2EFA9E5AF1E6.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 99,000,000 United States dollar | superseded | [clm_AF01B9D84E57](/claim/clm_AF01B9D84E57.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 895,000,000 United States dollar | superseded | [clm_021940492158](/claim/clm_021940492158.md)
- 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 906,000,000 United States dollar | superseded | [clm_DFAF55210899](/claim/clm_DFAF55210899.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_net_income | 227,000,000 United States dollar | superseded | [clm_09E7CA79E2C1](/claim/clm_09E7CA79E2C1.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_operating_income | 414,000,000 United States dollar | superseded | [clm_B0B77F4D2355](/claim/clm_B0B77F4D2355.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 108,000,000 United States dollar | superseded | [clm_EBA84637FBBE](/claim/clm_EBA84637FBBE.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 954,000,000 United States dollar | superseded | [clm_ABE8A12687C1](/claim/clm_ABE8A12687C1.md)
- 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 1,512,000,000 United States dollar | superseded | [clm_9AF736EF693E](/claim/clm_9AF736EF693E.md)
- 2011-12-31 to 2012-12-31 | money | net_income | 1,000,000,000 United States dollar | superseded | [clm_58E639A26546](/claim/clm_58E639A26546.md)
- 2011-12-31 to 2012-12-31 | money | operating_income | 1,756,000,000 United States dollar | superseded | [clm_FA62E19C8B03](/claim/clm_FA62E19C8B03.md)
- 2011-12-31 to 2012-12-31 | money | research_and_development | 388,000,000 United States dollar | superseded | [clm_073AE366EF90](/claim/clm_073AE366EF90.md)
- 2011-12-31 to 2012-12-31 | money | revenue | 3,711,000,000 United States dollar | superseded | [clm_5DCC855EAAE5](/claim/clm_5DCC855EAAE5.md)
- 2011-12-31 to 2012-06-30 | money | total_assets | 6,331,000,000 United States dollar | superseded | [clm_022ED0BCEC36](/claim/clm_022ED0BCEC36.md)
- 2011-12-31 to 2012-06-30 | money | total_equity | 4,899,000,000 United States dollar | superseded | [clm_6AFB4A75891C](/claim/clm_6AFB4A75891C.md)

## 2012

- 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 1,282,000,000 United States dollar | superseded | [clm_5DB2261B6E40](/claim/clm_5DB2261B6E40.md)
- 2012-03-31 to 2014-12-31 | money | employees | 3,539 | superseded | [clm_3226CE9BF611](/claim/clm_3226CE9BF611.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_net_income | 205,000,000 United States dollar | superseded | [clm_185A62CE8AA5](/claim/clm_185A62CE8AA5.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_operating_income | 381,000,000 United States dollar | superseded | [clm_3C1779C54599](/claim/clm_3C1779C54599.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 153,000,000 United States dollar | superseded | [clm_70D9863BAABC](/claim/clm_70D9863BAABC.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 1,058,000,000 United States dollar | superseded | [clm_D84992E1ED50](/claim/clm_D84992E1ED50.md)
- 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 2,098,000,000 United States dollar | superseded | [clm_D431859EBD72](/claim/clm_D431859EBD72.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_net_income | -157,000,000 United States dollar | superseded | [clm_5EDE7F4BFB92](/claim/clm_5EDE7F4BFB92.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_operating_income | -743,000,000 United States dollar | superseded | [clm_E30C145352D1](/claim/clm_E30C145352D1.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 705,000,000 United States dollar | superseded | [clm_7D948A9C6DEA](/claim/clm_7D948A9C6DEA.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 1,184,000,000 United States dollar | superseded | [clm_82590D4A0A41](/claim/clm_82590D4A0A41.md)
- 2012-06-30 to 2012-09-30 | money | total_assets | 14,928,000,000 United States dollar | superseded | [clm_71D02CE742E1](/claim/clm_71D02CE742E1.md)
- 2012-06-30 to 2012-09-30 | money | total_equity | 13,309,000,000 United States dollar | superseded | [clm_3EA126447EDA](/claim/clm_3EA126447EDA.md)
- 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 2,478,000,000 United States dollar | superseded | [clm_F4E24A877041](/claim/clm_F4E24A877041.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_net_income | -59,000,000 United States dollar | superseded | [clm_C06E2FA94C65](/claim/clm_C06E2FA94C65.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_operating_income | 377,000,000 United States dollar | superseded | [clm_5C7A45C13C73](/claim/clm_5C7A45C13C73.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 244,000,000 United States dollar | superseded | [clm_24BA32C2F4E5](/claim/clm_24BA32C2F4E5.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 1,262,000,000 United States dollar | superseded | [clm_384CA99CE7FA](/claim/clm_384CA99CE7FA.md)
- 2012-09-30 to 2012-12-31 | money | total_assets | 16,038,000,000 United States dollar | superseded | [clm_50E2C66CCD25](/claim/clm_50E2C66CCD25.md)
- 2012-09-30 to 2012-12-31 | money | total_equity | 14,174,000,000 United States dollar | superseded | [clm_24BED250210E](/claim/clm_24BED250210E.md)
- 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 2,384,000,000 United States dollar | superseded | [clm_6F2D0B4CA586](/claim/clm_6F2D0B4CA586.md)
- 2012-12-31 to 2013-12-31 | money | net_income | 53,000,000 United States dollar | superseded | [clm_52C962165857](/claim/clm_52C962165857.md)
- 2012-12-31 to 2013-12-31 | money | operating_income | 538,000,000 United States dollar | superseded | [clm_851655ACD34A](/claim/clm_851655ACD34A.md)
- 2012-12-31 to 2013-12-31 | money | research_and_development | 1,399,000,000 United States dollar | superseded | [clm_AC63094FDA69](/claim/clm_AC63094FDA69.md)
- 2012-12-31 to 2013-12-31 | money | revenue | 5,089,000,000 United States dollar | superseded | [clm_5E05399B253B](/claim/clm_5E05399B253B.md)
- 2012-12-31 to 2013-03-31 | money | total_assets | 15,103,000,000 United States dollar | superseded | [clm_5E0CEF308AA7](/claim/clm_5E0CEF308AA7.md)
- 2012-12-31 to 2013-03-31 | money | total_equity | 11,755,000,000 United States dollar | superseded | [clm_F4E75745A591](/claim/clm_F4E75745A591.md)

## 2013

- 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 2,325,000,000 United States dollar | superseded | [clm_BD72E64E39DE](/claim/clm_BD72E64E39DE.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_net_income | 219,000,000 United States dollar | superseded | [clm_161FBDE77E15](/claim/clm_161FBDE77E15.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_operating_income | 373,000,000 United States dollar | superseded | [clm_D0DE8BDB28DE](/claim/clm_D0DE8BDB28DE.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 293,000,000 United States dollar | superseded | [clm_D69D45E416EC](/claim/clm_D69D45E416EC.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 1,458,000,000 United States dollar | superseded | [clm_5E63F34CBF3C](/claim/clm_5E63F34CBF3C.md)
- 2013-03-31 to 2013-06-30 | money | total_assets | 15,163,000,000 United States dollar | superseded | [clm_99144461ECFC](/claim/clm_99144461ECFC.md)
- 2013-03-31 to 2013-06-30 | money | total_equity | 11,824,000,000 United States dollar | superseded | [clm_E6C7F0C99754](/claim/clm_E6C7F0C99754.md)
- 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 3,001,000,000 United States dollar | superseded | [clm_16BCA001E59D](/claim/clm_16BCA001E59D.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_net_income | 333,000,000 United States dollar | superseded | [clm_8C17D1F1FF4E](/claim/clm_8C17D1F1FF4E.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_operating_income | 562,000,000 United States dollar | superseded | [clm_A98AD201515F](/claim/clm_A98AD201515F.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 344,000,000 United States dollar | superseded | [clm_3EA5D1BA8599](/claim/clm_3EA5D1BA8599.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 1,813,000,000 United States dollar | superseded | [clm_7B50C3727CC0](/claim/clm_7B50C3727CC0.md)
- 2013-06-30 to 2013-09-30 | money | total_assets | 15,724,000,000 United States dollar | superseded | [clm_2E8A75F59C3D](/claim/clm_2E8A75F59C3D.md)
- 2013-06-30 to 2013-09-30 | money | total_equity | 12,349,000,000 United States dollar | superseded | [clm_AA89BF11B559](/claim/clm_AA89BF11B559.md)
- 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 3,100,000,000 United States dollar | superseded | [clm_713907AA3A99](/claim/clm_713907AA3A99.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_net_income | 425,000,000 United States dollar | superseded | [clm_8A7C9C9BA8E0](/claim/clm_8A7C9C9BA8E0.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_operating_income | 736,000,000 United States dollar | superseded | [clm_DE8AF488C031](/claim/clm_DE8AF488C031.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 369,000,000 United States dollar | superseded | [clm_45AC09BD2F90](/claim/clm_45AC09BD2F90.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 2,016,000,000 United States dollar | superseded | [clm_A9FDA00423F7](/claim/clm_A9FDA00423F7.md)
- 2013-09-30 to 2013-12-31 | money | total_assets | 14,933,000,000 United States dollar | superseded | [clm_648F3E10DA2C](/claim/clm_648F3E10DA2C.md)
- 2013-09-30 to 2013-12-31 | money | total_equity | 13,048,000,000 United States dollar | superseded | [clm_800BB7B0E7B9](/claim/clm_800BB7B0E7B9.md)
- 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 3,323,000,000 United States dollar | superseded | [clm_B883EEB50ED9](/claim/clm_B883EEB50ED9.md)
- 2013-12-31 to 2014-12-31 | money | net_income | 1,500,000,000 United States dollar | superseded | [clm_4B88946BD449](/claim/clm_4B88946BD449.md)
- 2013-12-31 to 2014-12-31 | money | operating_income | 2,804,000,000 United States dollar | superseded | [clm_63CBE4439AB2](/claim/clm_63CBE4439AB2.md)
- 2013-12-31 to 2014-12-31 | money | research_and_development | 1,415,000,000 United States dollar | superseded | [clm_D6B94BE3B003](/claim/clm_D6B94BE3B003.md)
- 2013-12-31 to 2014-12-31 | money | revenue | 7,872,000,000 United States dollar | superseded | [clm_8F7E37CADB78](/claim/clm_8F7E37CADB78.md)
- 2013-12-31 to 2014-03-31 | money | total_assets | 17,895,000,000 United States dollar | superseded | [clm_77081C529D2A](/claim/clm_77081C529D2A.md)
- 2013-12-31 to 2014-03-31 | money | total_equity | 15,470,000,000 United States dollar | superseded | [clm_09C3CD8ED8C3](/claim/clm_09C3CD8ED8C3.md)

## 2014

- 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 2,998,000,000 United States dollar | superseded | [clm_1FEE0E071801](/claim/clm_1FEE0E071801.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_net_income | 642,000,000 United States dollar | superseded | [clm_C0808A100AD1](/claim/clm_C0808A100AD1.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_operating_income | 1,075,000,000 United States dollar | superseded | [clm_0CF23C150E4D](/claim/clm_0CF23C150E4D.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 455,000,000 United States dollar | superseded | [clm_74FB91C6300E](/claim/clm_74FB91C6300E.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 2,502,000,000 United States dollar | superseded | [clm_DB240A043D31](/claim/clm_DB240A043D31.md)
- 2014-03-31 to 2014-06-30 | money | total_assets | 19,028,000,000 United States dollar | superseded | [clm_5EDB7023AAE7](/claim/clm_5EDB7023AAE7.md)
- 2014-03-31 to 2014-06-30 | money | total_equity | 16,737,000,000 United States dollar | superseded | [clm_AD73A3623717](/claim/clm_AD73A3623717.md)
- 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 4,384,000,000 United States dollar | superseded | [clm_959B31B489F6](/claim/clm_959B31B489F6.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_net_income | 791,000,000 United States dollar | superseded | [clm_E9E5C169B971](/claim/clm_E9E5C169B971.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_operating_income | 1,390,000,000 United States dollar | superseded | [clm_CED8AB686E18](/claim/clm_CED8AB686E18.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 492,000,000 United States dollar | superseded | [clm_FAD02B3569FB](/claim/clm_FAD02B3569FB.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 2,910,000,000 United States dollar | superseded | [clm_40D01E11D88D](/claim/clm_40D01E11D88D.md)
- 2014-06-30 to 2014-09-30 | money | total_assets | 20,769,000,000 United States dollar | superseded | [clm_52B922EB07BC](/claim/clm_52B922EB07BC.md)
- 2014-06-30 to 2014-09-30 | money | total_equity | 18,346,000,000 United States dollar | superseded | [clm_1F78FE6BE9E0](/claim/clm_1F78FE6BE9E0.md)
- 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 8,999,000,000 United States dollar | superseded | [clm_F32E353B388B](/claim/clm_F32E353B388B.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_net_income | 806,000,000 United States dollar | superseded | [clm_7C0CD9E44683](/claim/clm_7C0CD9E44683.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_operating_income | 1,397,000,000 United States dollar | superseded | [clm_825F03E7FE4B](/claim/clm_825F03E7FE4B.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 608,000,000 United States dollar | superseded | [clm_77E7C6625D29](/claim/clm_77E7C6625D29.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 3,203,000,000 United States dollar | superseded | [clm_22299784B7A3](/claim/clm_22299784B7A3.md)
- 2014-09-30 to 2014-12-31 | money | total_assets | 24,188,000,000 United States dollar | superseded | [clm_39EFB8AC3AC2](/claim/clm_39EFB8AC3AC2.md)
- 2014-09-30 to 2014-12-31 | money | total_equity | 21,238,000,000 United States dollar | superseded | [clm_76F16D48CF14](/claim/clm_76F16D48CF14.md)
- 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 4,315,000,000 United States dollar | superseded | [clm_E322753CE3C4](/claim/clm_E322753CE3C4.md)
- 2014-12-31 to 2015-03-31 | money | employees | 9,199 | superseded | [clm_C4F1324F5974](/claim/clm_C4F1324F5974.md)
- 2014-12-31 to 2015-12-31 | money | net_income | 2,940,000,000 United States dollar | superseded | [clm_CE1AC3D2E2A4](/claim/clm_CE1AC3D2E2A4.md)
- 2014-12-31 to 2015-12-31 | money | operating_income | 4,994,000,000 United States dollar | superseded | [clm_C7C78006D96B](/claim/clm_C7C78006D96B.md)
- 2014-12-31 to 2015-12-31 | money | research_and_development | 2,666,000,000 United States dollar | superseded | [clm_4C1049140B3A](/claim/clm_4C1049140B3A.md)
- 2014-12-31 to 2015-12-31 | money | revenue | 12,466,000,000 United States dollar | superseded | [clm_A2E510272112](/claim/clm_A2E510272112.md)
- 2014-12-31 to 2015-03-31 | money | total_assets | 40,184,000,000 United States dollar | superseded | [clm_E70732DEC93F](/claim/clm_E70732DEC93F.md)
- 2014-12-31 to 2015-03-31 | money | total_equity | 36,096,000,000 United States dollar | superseded | [clm_370490C48658](/claim/clm_370490C48658.md)

## 2015

- 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 3,419,000,000 United States dollar | superseded | [clm_4B75FC7D34F1](/claim/clm_4B75FC7D34F1.md)
- 2015-03-31 to 2015-09-30 | money | employees | 10,082 | superseded | [clm_47BF298A48CE](/claim/clm_47BF298A48CE.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_net_income | 512,000,000 United States dollar | superseded | [clm_E9A13F054E77](/claim/clm_E9A13F054E77.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_operating_income | 933,000,000 United States dollar | superseded | [clm_64D85FEDC452](/claim/clm_64D85FEDC452.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 1,062,000,000 United States dollar | superseded | [clm_CB4066D60A05](/claim/clm_CB4066D60A05.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 3,543,000,000 United States dollar | superseded | [clm_40B8D5EB525A](/claim/clm_40B8D5EB525A.md)
- 2015-03-31 to 2015-06-30 | money | total_assets | 42,007,000,000 United States dollar | superseded | [clm_21BC990F73B4](/claim/clm_21BC990F73B4.md)
- 2015-03-31 to 2015-06-30 | money | total_equity | 37,501,000,000 United States dollar | superseded | [clm_4F3483AA8BB1](/claim/clm_4F3483AA8BB1.md)
- 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 5,123,000,000 United States dollar | superseded | [clm_2A868BFB75E8](/claim/clm_2A868BFB75E8.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_net_income | 719,000,000 United States dollar | superseded | [clm_AA4F1D82308F](/claim/clm_AA4F1D82308F.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_operating_income | 1,273,000,000 United States dollar | superseded | [clm_F24958E06367](/claim/clm_F24958E06367.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 1,170,000,000 United States dollar | superseded | [clm_3D7894039D4B](/claim/clm_3D7894039D4B.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 4,042,000,000 United States dollar | superseded | [clm_A5317DA37E0B](/claim/clm_A5317DA37E0B.md)
- 2015-06-30 to 2015-09-30 | money | total_assets | 44,130,000,000 United States dollar | superseded | [clm_D7209DFD04F2](/claim/clm_D7209DFD04F2.md)
- 2015-06-30 to 2015-09-30 | money | total_equity | 39,452,000,000 United States dollar | superseded | [clm_0D607873ED53](/claim/clm_0D607873ED53.md)
- 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 4,308,000,000 United States dollar | superseded | [clm_EBC390D0A7D5](/claim/clm_EBC390D0A7D5.md)
- 2015-09-30 to 2016-12-31 | money | employees | 11,996 | superseded | [clm_C747837F70BA](/claim/clm_C747837F70BA.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_net_income | 896,000,000 United States dollar | superseded | [clm_CA12B8684A5B](/claim/clm_CA12B8684A5B.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_operating_income | 1,459,000,000 United States dollar | superseded | [clm_428FFFD46692](/claim/clm_428FFFD46692.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 1,271,000,000 United States dollar | superseded | [clm_1AFAD2D3450E](/claim/clm_1AFAD2D3450E.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 4,501,000,000 United States dollar | superseded | [clm_02A927CF348F](/claim/clm_02A927CF348F.md)
- 2015-09-30 to 2015-12-31 | money | total_assets | 46,469,000,000 United States dollar | superseded | [clm_A7D410716708](/claim/clm_A7D410716708.md)
- 2015-09-30 to 2015-12-31 | money | total_equity | 41,420,000,000 United States dollar | superseded | [clm_982C25787579](/claim/clm_982C25787579.md)
- 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 4,907,000,000 United States dollar | superseded | [clm_3894A8948734](/claim/clm_3894A8948734.md)
- 2015-12-31 to 2016-12-31 | money | net_income | 3,688,000,000 United States dollar | superseded | [clm_68D857D701FF](/claim/clm_68D857D701FF.md)
- 2015-12-31 to 2016-12-31 | money | operating_income | 6,225,000,000 United States dollar | superseded | [clm_9962C3054397](/claim/clm_9962C3054397.md)
- 2015-12-31 to 2016-12-31 | money | research_and_development | 4,816,000,000 United States dollar | superseded | [clm_7635FF5F589B](/claim/clm_7635FF5F589B.md)
- 2015-12-31 to 2016-12-31 | money | revenue | 17,928,000,000 United States dollar | superseded | [clm_6A12800D32A1](/claim/clm_6A12800D32A1.md)
- 2015-12-31 to 2016-03-31 | money | total_assets | 49,407,000,000 United States dollar | superseded | [clm_0264B5F5F1B1](/claim/clm_0264B5F5F1B1.md)
- 2015-12-31 to 2016-03-31 | money | total_equity | 44,218,000,000 United States dollar | superseded | [clm_9230A8287EE3](/claim/clm_9230A8287EE3.md)

## 2016

- 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 6,456,000,000 United States dollar | superseded | [clm_7017A41DFC1C](/claim/clm_7017A41DFC1C.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 1,510,000,000 United States dollar | superseded | [clm_0E5BB62BDCAE](/claim/clm_0E5BB62BDCAE.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_operating_income | 2,009,000,000 United States dollar | superseded | [clm_DF477779DE0E](/claim/clm_DF477779DE0E.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 1,343,000,000 United States dollar | superseded | [clm_54B820B1B521](/claim/clm_54B820B1B521.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 5,382,000,000 United States dollar | superseded | [clm_FFB5DFB94401](/claim/clm_FFB5DFB94401.md)
- 2016-03-31 to 2016-06-30 | money | total_assets | 52,262,000,000 United States dollar | superseded | [clm_64AA695DCFA1](/claim/clm_64AA695DCFA1.md)
- 2016-03-31 to 2016-06-30 | money | total_equity | 47,150,000,000 United States dollar | superseded | [clm_A3AB64EFB745](/claim/clm_A3AB64EFB745.md)
- 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 5,108,000,000 United States dollar | superseded | [clm_CDF27D040FD3](/claim/clm_CDF27D040FD3.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_net_income | 2,055,000,000 United States dollar | superseded | [clm_225931EB212B](/claim/clm_225931EB212B.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_operating_income | 2,746,000,000 United States dollar | superseded | [clm_A6E64A54CF5D](/claim/clm_A6E64A54CF5D.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 1,463,000,000 United States dollar | superseded | [clm_426F8DD4319C](/claim/clm_426F8DD4319C.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 6,436,000,000 United States dollar | superseded | [clm_CB001ED45B49](/claim/clm_CB001ED45B49.md)
- 2016-06-30 to 2016-09-30 | money | total_assets | 55,968,000,000 United States dollar | superseded | [clm_DD4BDCABABDC](/claim/clm_DD4BDCABABDC.md)
- 2016-06-30 to 2016-09-30 | money | total_equity | 50,383,000,000 United States dollar | superseded | [clm_45A83AF14483](/claim/clm_45A83AF14483.md)
- 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 6,038,000,000 United States dollar | superseded | [clm_A6A0F9B02544](/claim/clm_A6A0F9B02544.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_net_income | 2,379,000,000 United States dollar | superseded | [clm_5039FB0AAAB7](/claim/clm_5039FB0AAAB7.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | 3,122,000,000 United States dollar | superseded | [clm_2877E3092706](/claim/clm_2877E3092706.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 1,539,000,000 United States dollar | superseded | [clm_4D00C7D2551C](/claim/clm_4D00C7D2551C.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 7,011,000,000 United States dollar | superseded | [clm_EACF24E6D497](/claim/clm_EACF24E6D497.md)
- 2016-09-30 to 2016-12-31 | money | total_assets | 60,007,000,000 United States dollar | superseded | [clm_5AEC1BCC89F8](/claim/clm_5AEC1BCC89F8.md)
- 2016-09-30 to 2016-12-31 | money | total_equity | 54,115,000,000 United States dollar | superseded | [clm_FACB60938E31](/claim/clm_FACB60938E31.md)
- 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 8,903,000,000 United States dollar | superseded | [clm_809BFC6F1754](/claim/clm_809BFC6F1754.md)
- 2016-12-31 to 2017-03-31 | money | employees | 17,048 | superseded | [clm_22E133535EDB](/claim/clm_22E133535EDB.md)
- 2016-12-31 to 2017-12-31 | money | net_income | 10,217,000,000 United States dollar | superseded | [clm_04D53DB6C16B](/claim/clm_04D53DB6C16B.md)
- 2016-12-31 to 2017-12-31 | money | operating_income | 12,427,000,000 United States dollar | superseded | [clm_2B7892C0065D](/claim/clm_2B7892C0065D.md)
- 2016-12-31 to 2017-12-31 | money | research_and_development | 5,919,000,000 United States dollar | superseded | [clm_6FB84594B8DB](/claim/clm_6FB84594B8DB.md)
- 2016-12-31 to 2017-12-31 | money | revenue | 27,638,000,000 United States dollar | superseded | [clm_F45CDD3AF071](/claim/clm_F45CDD3AF071.md)
- 2016-12-31 to 2017-03-31 | money | total_assets | 64,961,000,000 United States dollar | superseded | [clm_2524FC6DE00B](/claim/clm_2524FC6DE00B.md)
- 2016-12-31 to 2017-03-31 | money | total_equity | 59,194,000,000 United States dollar | superseded | [clm_56A06C6D7ED1](/claim/clm_56A06C6D7ED1.md)

## 2017

- 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 7,104,000,000 United States dollar | superseded | [clm_646D8F4B8EB8](/claim/clm_646D8F4B8EB8.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 3,064,000,000 United States dollar | superseded | [clm_C1293E5AF4C3](/claim/clm_C1293E5AF4C3.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | 3,327,000,000 United States dollar | superseded | [clm_760C2D371F4F](/claim/clm_760C2D371F4F.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 1,834,000,000 United States dollar | superseded | [clm_F16FC916517B](/claim/clm_F16FC916517B.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 8,032,000,000 United States dollar | superseded | [clm_A57C7B8830EA](/claim/clm_A57C7B8830EA.md)
- 2017-03-31 to 2017-06-30 | money | total_assets | 68,714,000,000 United States dollar | superseded | [clm_F7E0B513E4EF](/claim/clm_F7E0B513E4EF.md)
- 2017-03-31 to 2017-06-30 | money | total_equity | 62,188,000,000 United States dollar | superseded | [clm_C32D1FD47C7C](/claim/clm_C32D1FD47C7C.md)
- 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 6,252,000,000 United States dollar | superseded | [clm_B9DDDC9CD0F9](/claim/clm_B9DDDC9CD0F9.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 3,894,000,000 United States dollar | superseded | [clm_8CC6154E5E2C](/claim/clm_8CC6154E5E2C.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_operating_income | 4,401,000,000 United States dollar | superseded | [clm_36EC4140DEB8](/claim/clm_36EC4140DEB8.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 1,919,000,000 United States dollar | superseded | [clm_CE2EBDB30D27](/claim/clm_CE2EBDB30D27.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 9,321,000,000 United States dollar | superseded | [clm_F918D459AC1D](/claim/clm_F918D459AC1D.md)
- 2017-06-30 to 2017-09-30 | money | total_assets | 73,843,000,000 United States dollar | superseded | [clm_D266D577859F](/claim/clm_D266D577859F.md)
- 2017-06-30 to 2017-09-30 | money | total_equity | 66,481,000,000 United States dollar | superseded | [clm_E4BCD53A5B6E](/claim/clm_E4BCD53A5B6E.md)
- 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 7,201,000,000 United States dollar | superseded | [clm_F3AA45AEB8E3](/claim/clm_F3AA45AEB8E3.md)
- 2017-09-30 to 2018-12-31 | money | employees | 23,165 | superseded | [clm_C80398D3C51F](/claim/clm_C80398D3C51F.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 4,707,000,000 United States dollar | superseded | [clm_C15BCB3335F6](/claim/clm_C15BCB3335F6.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | 5,122,000,000 United States dollar | superseded | [clm_800C5E8A1161](/claim/clm_800C5E8A1161.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 2,052,000,000 United States dollar | superseded | [clm_89EC6E873483](/claim/clm_89EC6E873483.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 10,328,000,000 United States dollar | superseded | [clm_7B39EB0A5878](/claim/clm_7B39EB0A5878.md)
- 2017-09-30 to 2017-12-31 | money | total_assets | 78,998,000,000 United States dollar | superseded | [clm_1616C0CCA514](/claim/clm_1616C0CCA514.md)
- 2017-09-30 to 2017-12-31 | money | total_equity | 71,208,000,000 United States dollar | superseded | [clm_A8D74F8E0666](/claim/clm_A8D74F8E0666.md)
- 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 8,079,000,000 United States dollar | superseded | [clm_2F84DCCE779D](/claim/clm_2F84DCCE779D.md)
- 2017-12-31 to 2018-12-31 | money | net_income | 15,934,000,000 United States dollar | superseded | [clm_2208C8B20A8F](/claim/clm_2208C8B20A8F.md)
- 2017-12-31 to 2018-12-31 | money | operating_income | 20,203,000,000 United States dollar | superseded | [clm_8999013797D3](/claim/clm_8999013797D3.md)
- 2017-12-31 to 2018-12-31 | money | research_and_development | 7,754,000,000 United States dollar | superseded | [clm_71519CB63367](/claim/clm_71519CB63367.md)
- 2017-12-31 to 2018-12-31 | money | revenue | 40,653,000,000 United States dollar | superseded | [clm_D8F187880A3D](/claim/clm_D8F187880A3D.md)
- 2017-12-31 to 2018-03-31 | money | total_assets | 84,524,000,000 United States dollar | superseded | [clm_15FF7E17030B](/claim/clm_15FF7E17030B.md)
- 2017-12-31 to 2018-03-31 | money | total_equity | 74,347,000,000 United States dollar | superseded | [clm_1BE403D0524C](/claim/clm_1BE403D0524C.md)

## 2018

- 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 12,082,000,000 United States dollar | superseded | [clm_265438FEB33C](/claim/clm_265438FEB33C.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 4,988,000,000 United States dollar | superseded | [clm_321477431879](/claim/clm_321477431879.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 5,449,000,000 United States dollar | superseded | [clm_690185EF4873](/claim/clm_690185EF4873.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 2,238,000,000 United States dollar | superseded | [clm_5771B6DF37BE](/claim/clm_5771B6DF37BE.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 11,966,000,000 United States dollar | superseded | [clm_9A737332A23F](/claim/clm_9A737332A23F.md)
- 2018-03-31 to 2018-06-30 | money | total_assets | 88,945,000,000 United States dollar | superseded | [clm_D13DDA5F82C6](/claim/clm_D13DDA5F82C6.md)
- 2018-03-31 to 2018-06-30 | money | total_equity | 77,620,000,000 United States dollar | superseded | [clm_C433E6A13403](/claim/clm_C433E6A13403.md)
- 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 11,552,000,000 United States dollar | superseded | [clm_BFB49D608BE4](/claim/clm_BFB49D608BE4.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 5,106,000,000 United States dollar | superseded | [clm_73C03348F621](/claim/clm_73C03348F621.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 5,863,000,000 United States dollar | superseded | [clm_F751899AE73F](/claim/clm_F751899AE73F.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 2,523,000,000 United States dollar | superseded | [clm_7BC4F2E96AE7](/claim/clm_7BC4F2E96AE7.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 13,231,000,000 United States dollar | superseded | [clm_7FADBD7A0A0E](/claim/clm_7FADBD7A0A0E.md)
- 2018-06-30 to 2018-09-30 | money | total_assets | 90,291,000,000 United States dollar | superseded | [clm_5DDCF19218B9](/claim/clm_5DDCF19218B9.md)
- 2018-06-30 to 2018-09-30 | money | total_equity | 79,382,000,000 United States dollar | superseded | [clm_DBBD10D5FC4B](/claim/clm_DBBD10D5FC4B.md)
- 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 9,637,000,000 United States dollar | superseded | [clm_D50A873E7BA9](/claim/clm_D50A873E7BA9.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 5,137,000,000 United States dollar | superseded | [clm_415D4C1826DE](/claim/clm_415D4C1826DE.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | 5,781,000,000 United States dollar | superseded | [clm_899567C06E9C](/claim/clm_899567C06E9C.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 2,657,000,000 United States dollar | superseded | [clm_A1F7F32D678D](/claim/clm_A1F7F32D678D.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 13,727,000,000 United States dollar | superseded | [clm_0702DFBBCBC2](/claim/clm_0702DFBBCBC2.md)
- 2018-09-30 to 2018-12-31 | money | total_assets | 92,452,000,000 United States dollar | superseded | [clm_2B09D8ADED73](/claim/clm_2B09D8ADED73.md)
- 2018-09-30 to 2018-12-31 | money | total_equity | 80,342,000,000 United States dollar | superseded | [clm_4E235390CA3D](/claim/clm_4E235390CA3D.md)
- 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 10,019,000,000 United States dollar | superseded | [clm_7ABC2BD024DC](/claim/clm_7ABC2BD024DC.md)
- 2018-12-31 to 2019-12-31 | money | employees | 35,587 | superseded | [clm_86DF9FC2180B](/claim/clm_86DF9FC2180B.md)
- 2018-12-31 to 2019-12-31 | money | net_income | 22,112,000,000 United States dollar | superseded | [clm_72BAD3F52C70](/claim/clm_72BAD3F52C70.md)
- 2018-12-31 to 2019-12-31 | money | operating_income | 24,913,000,000 United States dollar | superseded | [clm_B4D325BB94C1](/claim/clm_B4D325BB94C1.md)
- 2018-12-31 to 2019-12-31 | money | research_and_development | 10,273,000,000 United States dollar | superseded | [clm_8E60F9408EE9](/claim/clm_8E60F9408EE9.md)
- 2018-12-31 to 2019-12-31 | money | revenue | 55,838,000,000 United States dollar | superseded | [clm_8742410A3A54](/claim/clm_8742410A3A54.md)
- 2018-12-31 to 2019-03-31 | money | total_assets | 97,334,000,000 United States dollar | superseded | [clm_2F5AD112FB4B](/claim/clm_2F5AD112FB4B.md)
- 2018-12-31 to 2019-03-31 | money | total_equity | 84,127,000,000 United States dollar | superseded | [clm_64CF33239C5F](/claim/clm_64CF33239C5F.md)

## 2019

- 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 11,076,000,000 United States dollar | superseded | [clm_D7F253BFC555](/claim/clm_D7F253BFC555.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 2,429,000,000 United States dollar | superseded | [clm_9D150BC9672A](/claim/clm_9D150BC9672A.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 3,317,000,000 United States dollar | superseded | [clm_A7D6075670BD](/claim/clm_A7D6075670BD.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 2,860,000,000 United States dollar | superseded | [clm_6258B073CAED](/claim/clm_6258B073CAED.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 15,077,000,000 United States dollar | superseded | [clm_AB03212D6D85](/claim/clm_AB03212D6D85.md)
- 2019-03-31 to 2019-06-30 | money | total_assets | 109,477,000,000 United States dollar | superseded | [clm_A3726E008F9C](/claim/clm_A3726E008F9C.md)
- 2019-03-31 to 2019-06-30 | money | total_equity | 86,516,000,000 United States dollar | superseded | [clm_4A6D6B23E7D4](/claim/clm_4A6D6B23E7D4.md)
- 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 13,877,000,000 United States dollar | superseded | [clm_BB810D4B97F1](/claim/clm_BB810D4B97F1.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 2,616,000,000 United States dollar | superseded | [clm_91F021BED8D9](/claim/clm_91F021BED8D9.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | 4,626,000,000 United States dollar | superseded | [clm_E8FFF35A1695](/claim/clm_E8FFF35A1695.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 3,315,000,000 United States dollar | superseded | [clm_4F588151681A](/claim/clm_4F588151681A.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 16,886,000,000 United States dollar | superseded | [clm_B68FEB596DF8](/claim/clm_B68FEB596DF8.md)
- 2019-06-30 to 2019-09-30 | money | total_assets | 117,006,000,000 United States dollar | superseded | [clm_EA0268826F00](/claim/clm_EA0268826F00.md)
- 2019-06-30 to 2019-09-30 | money | total_equity | 88,762,000,000 United States dollar | superseded | [clm_6B35667FDEDE](/claim/clm_6B35667FDEDE.md)
- 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 15,979,000,000 United States dollar | superseded | [clm_F3CBA6D271B5](/claim/clm_F3CBA6D271B5.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 6,091,000,000 United States dollar | superseded | [clm_021096209423](/claim/clm_021096209423.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | 7,185,000,000 United States dollar | superseded | [clm_0316A065330D](/claim/clm_0316A065330D.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 3,548,000,000 United States dollar | superseded | [clm_CC20DA4922D3](/claim/clm_CC20DA4922D3.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 17,652,000,000 United States dollar | superseded | [clm_E3653BA3EF7A](/claim/clm_E3653BA3EF7A.md)
- 2019-09-30 to 2019-12-31 | money | total_assets | 124,418,000,000 United States dollar | superseded | [clm_1AA59C4AB1E9](/claim/clm_1AA59C4AB1E9.md)
- 2019-09-30 to 2019-12-31 | money | total_equity | 93,999,000,000 United States dollar | superseded | [clm_D01A832B581A](/claim/clm_D01A832B581A.md)
- 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 19,079,000,000 United States dollar | superseded | [clm_C9C626752091](/claim/clm_C9C626752091.md)
- 2019-12-31 to 2020-12-31 | money | employees | 44,942 | superseded | [clm_A76DF8E07F7F](/claim/clm_A76DF8E07F7F.md)
- 2019-12-31 to 2020-12-31 | money | net_income | 18,485,000,000 United States dollar | superseded | [clm_8B68D188B5F4](/claim/clm_8B68D188B5F4.md)
- 2019-12-31 to 2020-12-31 | money | operating_income | 23,986,000,000 United States dollar | superseded | [clm_06DE02ECA4D5](/claim/clm_06DE02ECA4D5.md)
- 2019-12-31 to 2020-12-31 | money | research_and_development | 13,600,000,000 United States dollar | superseded | [clm_AE247C718174](/claim/clm_AE247C718174.md)
- 2019-12-31 to 2020-12-31 | money | revenue | 70,697,000,000 United States dollar | superseded | [clm_B27AAAD644B0](/claim/clm_B27AAAD644B0.md)
- 2019-12-31 to 2020-03-31 | money | total_assets | 133,376,000,000 United States dollar | superseded | [clm_78BC1DEEEF63](/claim/clm_78BC1DEEEF63.md)
- 2019-12-31 to 2020-03-31 | money | total_equity | 101,054,000,000 United States dollar | superseded | [clm_E1521005DDB9](/claim/clm_E1521005DDB9.md)

## 2020

- 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 23,618,000,000 United States dollar | superseded | [clm_C433AFC107FE](/claim/clm_C433AFC107FE.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 4,902,000,000 United States dollar | superseded | [clm_62F2F6CB31AD](/claim/clm_62F2F6CB31AD.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | 5,893,000,000 United States dollar | superseded | [clm_F7E16E9B72D5](/claim/clm_F7E16E9B72D5.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 4,015,000,000 United States dollar | superseded | [clm_E1F1ABB236BC](/claim/clm_E1F1ABB236BC.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 17,737,000,000 United States dollar | superseded | [clm_8A8A7750669A](/claim/clm_8A8A7750669A.md)
- 2020-03-31 to 2020-06-30 | money | total_assets | 138,371,000,000 United States dollar | superseded | [clm_66B4CFF5C6DA](/claim/clm_66B4CFF5C6DA.md)
- 2020-03-31 to 2020-06-30 | money | total_equity | 105,304,000,000 United States dollar | superseded | [clm_B329E96E7231](/claim/clm_B329E96E7231.md)
- 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 21,045,000,000 United States dollar | superseded | [clm_4B8AAEB95341](/claim/clm_4B8AAEB95341.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_net_income | 5,178,000,000 United States dollar | superseded | [clm_3E747C0B6842](/claim/clm_3E747C0B6842.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | 5,963,000,000 United States dollar | superseded | [clm_87AEF146CE0A](/claim/clm_87AEF146CE0A.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 4,462,000,000 United States dollar | superseded | [clm_60C01BE4BB38](/claim/clm_60C01BE4BB38.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 18,687,000,000 United States dollar | superseded | [clm_4E9AA859E309](/claim/clm_4E9AA859E309.md)
- 2020-06-30 to 2020-09-30 | money | total_assets | 139,691,000,000 United States dollar | superseded | [clm_C018BA04A0AB](/claim/clm_C018BA04A0AB.md)
- 2020-06-30 to 2020-09-30 | money | total_equity | 110,447,000,000 United States dollar | superseded | [clm_767A7DB0B3C0](/claim/clm_767A7DB0B3C0.md)
- 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 11,617,000,000 United States dollar | superseded | [clm_B80276CE3787](/claim/clm_B80276CE3787.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 7,846,000,000 United States dollar | superseded | [clm_5EBC431FBCBE](/claim/clm_5EBC431FBCBE.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | 8,040,000,000 United States dollar | superseded | [clm_338A7E8AE371](/claim/clm_338A7E8AE371.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 4,763,000,000 United States dollar | superseded | [clm_001B6D1779DC](/claim/clm_001B6D1779DC.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 21,470,000,000 United States dollar | superseded | [clm_6433E4695247](/claim/clm_6433E4695247.md)
- 2020-09-30 to 2020-12-31 | money | total_assets | 146,437,000,000 United States dollar | superseded | [clm_68A879A53992](/claim/clm_68A879A53992.md)
- 2020-09-30 to 2020-12-31 | money | total_equity | 117,731,000,000 United States dollar | superseded | [clm_9AD0305E3050](/claim/clm_9AD0305E3050.md)
- 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 17,576,000,000 United States dollar | superseded | [clm_250C5118E540](/claim/clm_250C5118E540.md)
- 2020-12-31 to 2025-12-31 | money | employees | 58,604 | superseded | [clm_7D106FD78410](/claim/clm_7D106FD78410.md)
- 2020-12-31 to 2021-12-31 | money | net_income | 29,146,000,000 United States dollar | superseded | [clm_286F9C32CCE7](/claim/clm_286F9C32CCE7.md)
- 2020-12-31 to 2021-12-31 | money | operating_income | 32,671,000,000 United States dollar | superseded | [clm_BCA1BCBD197A](/claim/clm_BCA1BCBD197A.md)
- 2020-12-31 to 2021-12-31 | money | research_and_development | 18,447,000,000 United States dollar | superseded | [clm_F6557B4A62F9](/claim/clm_F6557B4A62F9.md)
- 2020-12-31 to 2021-12-31 | money | revenue | 85,965,000,000 United States dollar | superseded | [clm_F502969F034D](/claim/clm_F502969F034D.md)
- 2020-12-31 to 2021-03-31 | money | total_assets | 159,316,000,000 United States dollar | superseded | [clm_EB238D4A0C46](/claim/clm_EB238D4A0C46.md)
- 2020-12-31 to 2021-03-31 | money | total_equity | 128,290,000,000 United States dollar | superseded | [clm_1274DA099FA8](/claim/clm_1274DA099FA8.md)

## 2021

- 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 19,513,000,000 United States dollar | superseded | [clm_FE033341EC04](/claim/clm_FE033341EC04.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 9,497,000,000 United States dollar | superseded | [clm_D4BCDEC310E5](/claim/clm_D4BCDEC310E5.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | 11,378,000,000 United States dollar | superseded | [clm_1A62AD9D7B20](/claim/clm_1A62AD9D7B20.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 5,197,000,000 United States dollar | superseded | [clm_20877431560E](/claim/clm_20877431560E.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 26,171,000,000 United States dollar | superseded | [clm_801384A39DEC](/claim/clm_801384A39DEC.md)
- 2021-03-31 to 2021-06-30 | money | total_assets | 163,523,000,000 United States dollar | superseded | [clm_7091F5523E19](/claim/clm_7091F5523E19.md)
- 2021-03-31 to 2021-06-30 | money | total_equity | 133,657,000,000 United States dollar | superseded | [clm_7E31DF248165](/claim/clm_7E31DF248165.md)
- 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 16,186,000,000 United States dollar | superseded | [clm_525EE030782B](/claim/clm_525EE030782B.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 10,394,000,000 United States dollar | superseded | [clm_D1F44AD634E0](/claim/clm_D1F44AD634E0.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | 12,367,000,000 United States dollar | superseded | [clm_82E01C07BF47](/claim/clm_82E01C07BF47.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 6,096,000,000 United States dollar | superseded | [clm_164AF583CA7E](/claim/clm_164AF583CA7E.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 29,077,000,000 United States dollar | superseded | [clm_72D0C7CD7703](/claim/clm_72D0C7CD7703.md)
- 2021-06-30 to 2021-09-30 | money | total_assets | 170,609,000,000 United States dollar | superseded | [clm_F41E32D489BE](/claim/clm_F41E32D489BE.md)
- 2021-06-30 to 2021-09-30 | money | total_equity | 138,227,000,000 United States dollar | superseded | [clm_3F49B9510492](/claim/clm_3F49B9510492.md)
- 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 14,496,000,000 United States dollar | superseded | [clm_D868223C7799](/claim/clm_D868223C7799.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 9,194,000,000 United States dollar | superseded | [clm_6DF6AF6C2344](/claim/clm_6DF6AF6C2344.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 10,423,000,000 United States dollar | superseded | [clm_E28B677D3582](/claim/clm_E28B677D3582.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 6,316,000,000 United States dollar | superseded | [clm_E4F5746F3FA6](/claim/clm_E4F5746F3FA6.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 29,010,000,000 United States dollar | superseded | [clm_8B2DDB4F3648](/claim/clm_8B2DDB4F3648.md)
- 2021-09-30 to 2021-12-31 | money | total_assets | 169,585,000,000 United States dollar | superseded | [clm_D2A62DAE024D](/claim/clm_D2A62DAE024D.md)
- 2021-09-30 to 2021-12-31 | money | total_equity | 133,360,000,000 United States dollar | superseded | [clm_336ED9782EC5](/claim/clm_336ED9782EC5.md)
- 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 16,601,000,000 United States dollar | superseded | [clm_F10FF686D9EF](/claim/clm_F10FF686D9EF.md)
- 2021-12-31 to 2022-12-31 | money | net_income | 39,370,000,000 United States dollar | superseded | [clm_7F06C1B78678](/claim/clm_7F06C1B78678.md)
- 2021-12-31 to 2022-12-31 | money | operating_income | 46,753,000,000 United States dollar | superseded | [clm_EFDB45E21417](/claim/clm_EFDB45E21417.md)
- 2021-12-31 to 2022-12-31 | money | research_and_development | 24,655,000,000 United States dollar | superseded | [clm_A48139C67DE0](/claim/clm_A48139C67DE0.md)
- 2021-12-31 to 2022-12-31 | money | revenue | 117,929,000,000 United States dollar | superseded | [clm_E06B74A098AA](/claim/clm_E06B74A098AA.md)
- 2021-12-31 to 2022-03-31 | money | total_assets | 165,987,000,000 United States dollar | superseded | [clm_F5E3A7C8BB5A](/claim/clm_F5E3A7C8BB5A.md)
- 2021-12-31 to 2022-03-31 | money | total_equity | 124,879,000,000 United States dollar | superseded | [clm_D2E5A9E566E3](/claim/clm_D2E5A9E566E3.md)

## 2022

- 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 14,886,000,000 United States dollar | superseded | [clm_D7B018C6F4A2](/claim/clm_D7B018C6F4A2.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 7,465,000,000 United States dollar | superseded | [clm_FDCF697215DD](/claim/clm_FDCF697215DD.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | 8,524,000,000 United States dollar | superseded | [clm_6A2039EF7860](/claim/clm_6A2039EF7860.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 7,707,000,000 United States dollar | superseded | [clm_3541D1469550](/claim/clm_3541D1469550.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 27,908,000,000 United States dollar | superseded | [clm_E20C01F16CD6](/claim/clm_E20C01F16CD6.md)
- 2022-03-31 to 2022-06-30 | money | total_assets | 164,218,000,000 United States dollar | superseded | [clm_1E14EB99BA92](/claim/clm_1E14EB99BA92.md)
- 2022-03-31 to 2022-06-30 | money | total_equity | 123,228,000,000 United States dollar | superseded | [clm_A2432E9701D6](/claim/clm_A2432E9701D6.md)
- 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 12,681,000,000 United States dollar | superseded | [clm_FC2EF45EEC15](/claim/clm_FC2EF45EEC15.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 6,687,000,000 United States dollar | superseded | [clm_ED2CC46B7698](/claim/clm_ED2CC46B7698.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 8,358,000,000 United States dollar | superseded | [clm_0085957ECC83](/claim/clm_0085957ECC83.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 8,690,000,000 United States dollar | superseded | [clm_442770C84F12](/claim/clm_442770C84F12.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 28,822,000,000 United States dollar | superseded | [clm_0E69D4AC09ED](/claim/clm_0E69D4AC09ED.md)
- 2022-06-30 to 2022-09-30 | money | total_assets | 169,779,000,000 United States dollar | superseded | [clm_B49C5882CF33](/claim/clm_B49C5882CF33.md)
- 2022-06-30 to 2022-09-30 | money | total_equity | 125,767,000,000 United States dollar | superseded | [clm_F4261F5BA94E](/claim/clm_F4261F5BA94E.md)
- 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 14,308,000,000 United States dollar | superseded | [clm_9BA086FCB48A](/claim/clm_9BA086FCB48A.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 4,395,000,000 United States dollar | superseded | [clm_AE5659F73088](/claim/clm_AE5659F73088.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 5,664,000,000 United States dollar | superseded | [clm_B286DCEF4F1F](/claim/clm_B286DCEF4F1F.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 9,170,000,000 United States dollar | superseded | [clm_8F3BEFBD247A](/claim/clm_8F3BEFBD247A.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 27,714,000,000 United States dollar | superseded | [clm_518459593E74](/claim/clm_518459593E74.md)
- 2022-09-30 to 2022-12-31 | money | total_assets | 178,894,000,000 United States dollar | superseded | [clm_D5276763E6CA](/claim/clm_D5276763E6CA.md)
- 2022-09-30 to 2022-12-31 | money | total_equity | 124,094,000,000 United States dollar | superseded | [clm_DB1DE85442B9](/claim/clm_DB1DE85442B9.md)
- 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 14,681,000,000 United States dollar | superseded | [clm_47ECBD788E51](/claim/clm_47ECBD788E51.md)
- 2022-12-31 to 2023-12-31 | money | net_income | 23,200,000,000 United States dollar | superseded | [clm_6C5713A8244F](/claim/clm_6C5713A8244F.md)
- 2022-12-31 to 2023-12-31 | money | operating_income | 28,944,000,000 United States dollar | superseded | [clm_FAE4A90D98C6](/claim/clm_FAE4A90D98C6.md)
- 2022-12-31 to 2023-12-31 | money | research_and_development | 35,338,000,000 United States dollar | superseded | [clm_BFB00B1A8B7E](/claim/clm_BFB00B1A8B7E.md)
- 2022-12-31 to 2023-12-31 | money | revenue | 116,609,000,000 United States dollar | superseded | [clm_9223C221B63F](/claim/clm_9223C221B63F.md)
- 2022-12-31 to 2023-03-31 | money | total_assets | 185,727,000,000 United States dollar | superseded | [clm_8C306D8DED03](/claim/clm_8C306D8DED03.md)
- 2022-12-31 to 2023-03-31 | money | total_equity | 125,713,000,000 United States dollar | superseded | [clm_BEEF562B96F7](/claim/clm_BEEF562B96F7.md)

## 2023

- 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 11,551,000,000 United States dollar | superseded | [clm_628A56319337](/claim/clm_628A56319337.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 5,709,000,000 United States dollar | superseded | [clm_C538D4C2672F](/claim/clm_C538D4C2672F.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 7,227,000,000 United States dollar | superseded | [clm_BCABD690D10F](/claim/clm_BCABD690D10F.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 9,381,000,000 United States dollar | superseded | [clm_8A245712C844](/claim/clm_8A245712C844.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 28,645,000,000 United States dollar | superseded | [clm_AECDBAC61429](/claim/clm_AECDBAC61429.md)
- 2023-03-31 to 2023-06-30 | money | total_assets | 184,491,000,000 United States dollar | superseded | [clm_83CFA3D09C60](/claim/clm_83CFA3D09C60.md)
- 2023-03-31 to 2023-06-30 | money | total_equity | 124,795,000,000 United States dollar | superseded | [clm_8C9FBDBCC250](/claim/clm_8C9FBDBCC250.md)
- 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 28,785,000,000 United States dollar | superseded | [clm_C69C835F7CFF](/claim/clm_C69C835F7CFF.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 7,788,000,000 United States dollar | superseded | [clm_35EC20145D85](/claim/clm_35EC20145D85.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | 9,392,000,000 United States dollar | superseded | [clm_295D0BC7922A](/claim/clm_295D0BC7922A.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 9,344,000,000 United States dollar | superseded | [clm_EA78DAAE9D2E](/claim/clm_EA78DAAE9D2E.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 31,999,000,000 United States dollar | superseded | [clm_CD2726400F8F](/claim/clm_CD2726400F8F.md)
- 2023-06-30 to 2023-09-30 | money | total_assets | 206,688,000,000 United States dollar | superseded | [clm_0CFEA0510811](/claim/clm_0CFEA0510811.md)
- 2023-06-30 to 2023-09-30 | money | total_equity | 134,033,000,000 United States dollar | superseded | [clm_D2AB48E4FC8D](/claim/clm_D2AB48E4FC8D.md)
- 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 36,890,000,000 United States dollar | superseded | [clm_BF15352EEBED](/claim/clm_BF15352EEBED.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 11,583,000,000 United States dollar | superseded | [clm_A3F333BB2A2D](/claim/clm_A3F333BB2A2D.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | 13,748,000,000 United States dollar | superseded | [clm_7372C9C4B4EA](/claim/clm_7372C9C4B4EA.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 9,241,000,000 United States dollar | superseded | [clm_2A489D0888BC](/claim/clm_2A489D0888BC.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 34,146,000,000 United States dollar | superseded | [clm_B8F6883640D7](/claim/clm_B8F6883640D7.md)
- 2023-09-30 to 2023-12-31 | money | total_assets | 216,274,000,000 United States dollar | superseded | [clm_2E6BD6DE302C](/claim/clm_2E6BD6DE302C.md)
- 2023-09-30 to 2023-12-31 | money | total_equity | 142,873,000,000 United States dollar | superseded | [clm_96F47A0C5426](/claim/clm_96F47A0C5426.md)
- 2023-11-16 | money | partnership | Christian Louboutin | valid | [clm_9BD022DEA8F2](/claim/clm_9BD022DEA8F2.md)
- 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 41,862,000,000 United States dollar | superseded | [clm_0ABA533D145D](/claim/clm_0ABA533D145D.md)
- 2023-12-31 to 2024-12-31 | money | net_income | 39,098,000,000 United States dollar | superseded | [clm_9D1C2D42D123](/claim/clm_9D1C2D42D123.md)
- 2023-12-31 to 2024-12-31 | money | operating_income | 46,751,000,000 United States dollar | superseded | [clm_FEA363582B36](/claim/clm_FEA363582B36.md)
- 2023-12-31 to 2024-12-31 | money | research_and_development | 38,483,000,000 United States dollar | superseded | [clm_0B08424F704B](/claim/clm_0B08424F704B.md)
- 2023-12-31 to 2024-12-31 | money | revenue | 134,902,000,000 United States dollar | superseded | [clm_CFBAC4968C8F](/claim/clm_CFBAC4968C8F.md)
- 2023-12-31 to 2024-03-31 | money | total_assets | 229,623,000,000 United States dollar | superseded | [clm_A06F0E1C35F0](/claim/clm_A06F0E1C35F0.md)
- 2023-12-31 to 2024-03-31 | money | total_equity | 153,168,000,000 United States dollar | superseded | [clm_263026C23CF1](/claim/clm_263026C23CF1.md)

## 2024

- 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 32,307,000,000 United States dollar | superseded | [clm_208AADF8887E](/claim/clm_208AADF8887E.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 12,369,000,000 United States dollar | superseded | [clm_A55CCBE2E1F6](/claim/clm_A55CCBE2E1F6.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | 13,818,000,000 United States dollar | superseded | [clm_64C181DFDB5A](/claim/clm_64C181DFDB5A.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 9,978,000,000 United States dollar | superseded | [clm_E55CAFBD3041](/claim/clm_E55CAFBD3041.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 36,455,000,000 United States dollar | superseded | [clm_3E44BDC717E8](/claim/clm_3E44BDC717E8.md)
- 2024-03-31 to 2024-06-30 | money | total_assets | 222,844,000,000 United States dollar | superseded | [clm_B1C03011A08A](/claim/clm_B1C03011A08A.md)
- 2024-03-31 to 2024-06-30 | money | total_equity | 149,529,000,000 United States dollar | superseded | [clm_DE4B5615D3BF](/claim/clm_DE4B5615D3BF.md)
- 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 32,045,000,000 United States dollar | superseded | [clm_8BDD00A016F3](/claim/clm_8BDD00A016F3.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 13,465,000,000 United States dollar | superseded | [clm_07FB3E85575E](/claim/clm_07FB3E85575E.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | 14,847,000,000 United States dollar | superseded | [clm_DB4EE2FE4E6D](/claim/clm_DB4EE2FE4E6D.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 10,537,000,000 United States dollar | superseded | [clm_BCA12AC9E43A](/claim/clm_BCA12AC9E43A.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 39,071,000,000 United States dollar | superseded | [clm_F3260B8A15AB](/claim/clm_F3260B8A15AB.md)
- 2024-06-30 to 2024-09-30 | money | total_assets | 230,238,000,000 United States dollar | superseded | [clm_1955B2299FA5](/claim/clm_1955B2299FA5.md)
- 2024-06-30 to 2024-09-30 | money | total_equity | 156,763,000,000 United States dollar | superseded | [clm_2B7696A239E0](/claim/clm_2B7696A239E0.md)
- 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 43,852,000,000 United States dollar | superseded | [clm_9978C1D8B9C6](/claim/clm_9978C1D8B9C6.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 15,688,000,000 United States dollar | superseded | [clm_9227AB1FC6BA](/claim/clm_9227AB1FC6BA.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | 17,350,000,000 United States dollar | superseded | [clm_AE3AA261A7D3](/claim/clm_AE3AA261A7D3.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 11,177,000,000 United States dollar | superseded | [clm_E356C73F7048](/claim/clm_E356C73F7048.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 40,589,000,000 United States dollar | superseded | [clm_82F86E6935E2](/claim/clm_82F86E6935E2.md)
- 2024-09-30 to 2024-12-31 | money | total_assets | 256,408,000,000 United States dollar | superseded | [clm_702CB83E0745](/claim/clm_702CB83E0745.md)
- 2024-09-30 to 2024-12-31 | money | total_equity | 164,529,000,000 United States dollar | superseded | [clm_48AEC7056E06](/claim/clm_48AEC7056E06.md)
- 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 43,889,000,000 United States dollar | superseded | [clm_E7EAF804A64B](/claim/clm_E7EAF804A64B.md)
- 2024-12-31 to 2025-12-31 | money | net_income | 62,360,000,000 United States dollar | superseded | [clm_6B0C9C34D890](/claim/clm_6B0C9C34D890.md)
- 2024-12-31 to 2025-12-31 | money | operating_income | 69,380,000,000 United States dollar | superseded | [clm_6413017F9597](/claim/clm_6413017F9597.md)
- 2024-12-31 to 2025-12-31 | money | research_and_development | 43,873,000,000 United States dollar | superseded | [clm_3E824B543B15](/claim/clm_3E824B543B15.md)
- 2024-12-31 to 2025-12-31 | money | revenue | 164,501,000,000 United States dollar | superseded | [clm_878CC92E9B69](/claim/clm_878CC92E9B69.md)
- 2024-12-31 to 2025-03-31 | money | total_assets | 276,054,000,000 United States dollar | superseded | [clm_5EC328E5447B](/claim/clm_5EC328E5447B.md)
- 2024-12-31 to 2025-03-31 | money | total_equity | 182,637,000,000 United States dollar | superseded | [clm_A1DB96B7325F](/claim/clm_A1DB96B7325F.md)

## 2025

- 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 28,750,000,000 United States dollar | superseded | [clm_384047A3BC9E](/claim/clm_384047A3BC9E.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 16,644,000,000 United States dollar | superseded | [clm_C1D8F094A622](/claim/clm_C1D8F094A622.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 17,555,000,000 United States dollar | superseded | [clm_FC93EC58BDC5](/claim/clm_FC93EC58BDC5.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 12,150,000,000 United States dollar | superseded | [clm_EDBAC33BAB17](/claim/clm_EDBAC33BAB17.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 42,314,000,000 United States dollar | superseded | [clm_B1FC5B32304E](/claim/clm_B1FC5B32304E.md)
- 2025-03-31 to 2025-06-30 | money | total_assets | 280,213,000,000 United States dollar | superseded | [clm_32F92B339E70](/claim/clm_32F92B339E70.md)
- 2025-03-31 to 2025-06-30 | money | total_equity | 185,029,000,000 United States dollar | superseded | [clm_8614476D6954](/claim/clm_8614476D6954.md)
- 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 12,005,000,000 United States dollar | superseded | [clm_E8C3F6CC9903](/claim/clm_E8C3F6CC9903.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 18,337,000,000 United States dollar | superseded | [clm_5C0B7FF76739](/claim/clm_5C0B7FF76739.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 20,441,000,000 United States dollar | superseded | [clm_C4447E6D7349](/claim/clm_C4447E6D7349.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 12,942,000,000 United States dollar | superseded | [clm_6E4B4B3D2E55](/claim/clm_6E4B4B3D2E55.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 47,516,000,000 United States dollar | superseded | [clm_A09C2C7F2B32](/claim/clm_A09C2C7F2B32.md)
- 2025-06-30 to 2025-09-30 | money | total_assets | 294,744,000,000 United States dollar | superseded | [clm_A4D3F8978AFD](/claim/clm_A4D3F8978AFD.md)
- 2025-06-30 to 2025-09-30 | money | total_equity | 195,070,000,000 United States dollar | superseded | [clm_E33D4C4D8A38](/claim/clm_E33D4C4D8A38.md)
- 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 10,187,000,000 United States dollar | superseded | [clm_015DF1465EFA](/claim/clm_015DF1465EFA.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 2,709,000,000 United States dollar | superseded | [clm_06A6CBD529E5](/claim/clm_06A6CBD529E5.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 20,535,000,000 United States dollar | superseded | [clm_A76B68048471](/claim/clm_A76B68048471.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 15,144,000,000 United States dollar | superseded | [clm_145FE07880ED](/claim/clm_145FE07880ED.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 51,242,000,000 United States dollar | superseded | [clm_9118DE18D549](/claim/clm_9118DE18D549.md)
- 2025-09-30 to 2025-12-31 | money | total_assets | 303,844,000,000 United States dollar | superseded | [clm_411FC3EE5182](/claim/clm_411FC3EE5182.md)
- 2025-09-30 to 2025-12-31 | money | total_equity | 194,066,000,000 United States dollar | superseded | [clm_66DDD6AB78B9](/claim/clm_66DDD6AB78B9.md)
- 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 35,873,000,000 United States dollar | superseded | [clm_0E311E7BF0A3](/claim/clm_0E311E7BF0A3.md)
- 2025-12-31 | money | employees | 78,865 | valid | [clm_9A18E40DB43A](/claim/clm_9A18E40DB43A.md)
- 2025-12-31 | money | net_income | 60,458,000,000 United States dollar | valid | [clm_72FCE33DFF8E](/claim/clm_72FCE33DFF8E.md)
- 2025-12-31 | money | operating_income | 83,276,000,000 United States dollar | valid | [clm_56F33FD8227B](/claim/clm_56F33FD8227B.md)
- 2025-12-31 | money | research_and_development | 57,372,000,000 United States dollar | valid | [clm_00DB96B42D29](/claim/clm_00DB96B42D29.md)
- 2025-12-31 | money | revenue | 200,966,000,000 United States dollar | valid | [clm_A3DE21772E07](/claim/clm_A3DE21772E07.md)
- 2025-12-31 to 2026-03-31 | money | total_assets | 366,021,000,000 United States dollar | superseded | [clm_0A42D46A9378](/claim/clm_0A42D46A9378.md)
- 2025-12-31 to 2026-03-31 | money | total_equity | 217,243,000,000 United States dollar | superseded | [clm_07FC01A2E78A](/claim/clm_07FC01A2E78A.md)

## 2026

- 2026-03-24 | money | partnership | [Arm](/record/arm.md) | valid | [clm_CAB81B27C00C](/claim/clm_CAB81B27C00C.md)
- 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 23,426,000,000 United States dollar | superseded | [clm_304772B3184E](/claim/clm_304772B3184E.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 26,773,000,000 United States dollar | superseded | [clm_5256917749FA](/claim/clm_5256917749FA.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 22,872,000,000 United States dollar | superseded | [clm_15CC2F4927A1](/claim/clm_15CC2F4927A1.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 17,699,000,000 United States dollar | superseded | [clm_1D9AD653D242](/claim/clm_1D9AD653D242.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 56,311,000,000 United States dollar | superseded | [clm_4A7A16D20072](/claim/clm_4A7A16D20072.md)
- 2026-03-31 to 2026-06-30 | money | total_assets | 395,250,000,000 United States dollar | superseded | [clm_9B88A51C589C](/claim/clm_9B88A51C589C.md)
- 2026-03-31 to 2026-06-30 | money | total_equity | 243,681,000,000 United States dollar | superseded | [clm_EAC07710ECE4](/claim/clm_EAC07710ECE4.md)
- 2026-04-14 | money | partnership | [Broadcom](/record/broadcom.md) | valid | [clm_1F89339C607D](/claim/clm_1F89339C607D.md)
- 2026-04-20 | money | investment | Fiber technician training program | valid | [clm_D2D8C54F9E6C](/claim/clm_D2D8C54F9E6C.md)
- 2026-04-20 | money | partnership | CBRE | valid | [clm_537E7035DAF8](/claim/clm_537E7035DAF8.md)
- 2026-04-24 | money | partnership | AWS | valid | [clm_3EB86600C7DF](/claim/clm_3EB86600C7DF.md)
- 2026-05-11 | money | partnership | Festival de Cannes | valid | [clm_8F0C571168C9](/claim/clm_8F0C571168C9.md)
- 2026-06-23 | money | partnership | EssilorLuxottica | valid | [clm_2B32DDDBA700](/claim/clm_2B32DDDBA700.md)
- 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 15,462,000,000 United States dollar | superseded | [clm_D253D8AB7A56](/claim/clm_D253D8AB7A56.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 15,848,000,000 United States dollar | superseded | [clm_9884B1E1EF20](/claim/clm_9884B1E1EF20.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 18,775,000,000 United States dollar | superseded | [clm_59F7132246EE](/claim/clm_59F7132246EE.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 21,656,000,000 United States dollar | superseded | [clm_7D4D3FF7617E](/claim/clm_7D4D3FF7617E.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 60,801,000,000 United States dollar | superseded | [clm_37620334E05C](/claim/clm_37620334E05C.md)
- 2026-06-30 to 2026-09-30 | money | total_assets | 449,956,000,000 United States dollar | superseded | [clm_5F2A3F3F5D69](/claim/clm_5F2A3F3F5D69.md)
- 2026-06-30 to 2026-09-30 | money | total_equity | 261,221,000,000 United States dollar | superseded | [clm_9A34EA61C940](/claim/clm_9A34EA61C940.md)
- 2026-07-28 | money | investment | El Paso | valid | [clm_528F52E056DE](/claim/clm_528F52E056DE.md)
- 2026-08-13 | money | partnership | Vision Ireland | valid | [clm_F026ABE3EC8B](/claim/clm_F026ABE3EC8B.md)
- 2026-08-26 | money | partnership | 51 state attorneys general | valid | [clm_D9AB02DA3F38](/claim/clm_D9AB02DA3F38.md)
- 2026-09-16 | money | customer | smartARM | valid | [clm_E605BC55CD1A](/claim/clm_E605BC55CD1A.md)
- 2026-09-30 | money | cash_and_equivalents | 11,222,000,000 United States dollar | valid | [clm_F0C2E8D209FD](/claim/clm_F0C2E8D209FD.md)
- 2026-09-30 | money | quarterly_net_income | 9,860,000,000 United States dollar | valid | [clm_B418B5609B78](/claim/clm_B418B5609B78.md)
- 2026-09-30 | money | quarterly_operating_income | 12,988,000,000 United States dollar | valid | [clm_1FD9AD3D23FF](/claim/clm_1FD9AD3D23FF.md)
- 2026-09-30 | money | quarterly_research_and_development | 20,054,000,000 United States dollar | valid | [clm_BB721372907D](/claim/clm_BB721372907D.md)
- 2026-09-30 | money | quarterly_revenue | 64,601,000,000 United States dollar | valid | [clm_5EAC36935E4B](/claim/clm_5EAC36935E4B.md)
- 2026-09-30 | money | total_assets | 478,836,000,000 United States dollar | valid | [clm_C88298152BED](/claim/clm_C88298152BED.md)
- 2026-09-30 | money | total_equity | 272,386,000,000 United States dollar | valid | [clm_92931A637613](/claim/clm_92931A637613.md)
- 2026-10-14 | money | partnership | Pinacoteca di Brera | valid | [clm_67E92D5E64A1](/claim/clm_67E92D5E64A1.md)
- 2026-10-28 | money | market_cap | 1,592,000,000,000 United States dollar | unverified | [clm_2C2AD719531A](/claim/clm_2C2AD719531A.md)
- 2026-10-28 | money | partnership | Five US universities | valid | [clm_677C7BDD71AA](/claim/clm_677C7BDD71AA.md)
- 2026-10-29 | money | partnership | INCA | valid | [clm_250AD535D94F](/claim/clm_250AD535D94F.md)
- 2026-10-29 | money | partnership | CNIB | valid | [clm_D13B48A4B8B9](/claim/clm_D13B48A4B8B9.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.